Now that Lanstead financing deal has finished and the tax loss selling has finished we have now clear air going forward.Dr T at the AGM said a deal would be completed in the September quarter(11 weeks to the end of September) deal could be for individual products ,for territories or for the entire Neuren business.
What are the possible options?????.
1.Complete sale of the business to Acadia,Takeda or other companies keen to get further into this space.
2.Deal for NNZ2591.
3.Deal for the Rest of World for trofinetide .
4.Backdoor listing on the Nasdaq.(US market is substantially better than our Australian market for biotechs)
We have not long to wait for an event to occur .
Deal Happening
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.16 |
Change
-0.230(1.19%) |
Mkt cap ! $2.443B | |||
| Open | High | Low | Value | Volume |
| $19.55 | $19.65 | $18.88 | $5.897M | 308.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 871 | $19.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.16 | 401 | 21 |
View Market Depth
| Last trade - 15.22pm 31/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |